GLUE
Price
$4.14
Change
-$0.08 (-1.90%)
Updated
May 9, 02:38 PM (EDT)
Capitalization
236.81M
90 days until earnings call
IMNM
Price
$7.55
Change
-$0.16 (-2.08%)
Updated
May 9, 02:31 PM (EDT)
Capitalization
670.86M
96 days until earnings call
Ad is loading...

GLUE vs IMNM

Header iconGLUE vs IMNM Comparison
Open Charts GLUE vs IMNMBanner chart's image
Monte Rosa Therapeutics
Price$4.14
Change-$0.08 (-1.90%)
Volume$200
Capitalization236.81M
Immunome
Price$7.55
Change-$0.16 (-2.08%)
Volume$113
Capitalization670.86M
GLUE vs IMNM Comparison Chart
Loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLUE vs. IMNM commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and IMNM is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (GLUE: $4.22 vs. IMNM: $7.71)
Brand notoriety: GLUE and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 88% vs. IMNM: 61%
Market capitalization -- GLUE: $236.81M vs. IMNM: $670.86M
GLUE [@Biotechnology] is valued at $236.81M. IMNM’s [@Biotechnology] market capitalization is $670.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, GLUE is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 4 TA indicator(s) are bullish while IMNM’s TA Score has 5 bullish TA indicator(s).

  • GLUE’s TA Score: 4 bullish, 4 bearish.
  • IMNM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both GLUE and IMNM are a good buy in the short-term.

Price Growth

GLUE (@Biotechnology) experienced а -13.88% price change this week, while IMNM (@Biotechnology) price change was -12.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.87%. For the same industry, the average monthly price growth was +10.11%, and the average quarterly price growth was -13.97%.

Reported Earning Dates

GLUE is expected to report earnings on Aug 07, 2025.

IMNM is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (-5.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($671M) has a higher market cap than GLUE($237M). IMNM YTD gains are higher at: -27.401 vs. GLUE (-39.193). IMNM has higher annual earnings (EBITDA): -109.95M vs. GLUE (-121.07M). GLUE (242M) and IMNM (240M) have equal amount of cash in the bank . IMNM has less debt than GLUE: IMNM (2.72M) vs GLUE (43.7M). GLUE has higher revenues than IMNM: GLUE (15M) vs IMNM (10.1M).
GLUEIMNMGLUE / IMNM
Capitalization237M671M35%
EBITDA-121.07M-109.95M110%
Gain YTD-39.193-27.401143%
P/E RatioN/AN/A-
Revenue15M10.1M149%
Total Cash242M240M101%
Total Debt43.7M2.72M1,606%
TECHNICAL ANALYSIS
Technical Analysis
GLUEIMNM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 17 days ago
88%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OEPSX45.68N/A
N/A
Oil Equipment&Svcs UltraSector Pro Svc
ASDEX116.98N/A
N/A
American Century Select R6
GMXRX14.39N/A
N/A
Nationwide Mid Cap Market Idx R
MXBUX8.50N/A
N/A
Empower S&P Mid Cap 400® Index L
TLACX10.64N/A
N/A
Transamerica Large Core ESG A

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+3.77%
IDYA - IMNM
57%
Loosely correlated
+1.96%
KYMR - IMNM
56%
Loosely correlated
+5.70%
RXRX - IMNM
54%
Loosely correlated
+4.77%
BEAM - IMNM
54%
Loosely correlated
+6.32%
CCCC - IMNM
52%
Loosely correlated
+2.67%
More